Soleno Therapeutics (SLNO) Treasury Shares (2016 - 2026)
Soleno Therapeutics (SLNO) reported Treasury Shares of $1.2 million for Q1 2026, up 220.05% year-over-year from $361991.0 in Q1 2025, and up 161.35% quarter-over-quarter from $443291.0 in Q4 2025.
Soleno Therapeutics (SLNO) Treasury Shares (2016 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has 9 years of Treasury Shares data on file, last reported at $1.2 million in Q1 2026.
- Treasury Shares for Q1 2026 came in at $1.2 million, up 220.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (up 220.05% YoY), and the FY2025 annual result was $443291.0, down 52.83% from the prior year.
- Treasury Shares climbed to $1.2 million in Q1 2026 per SLNO's latest filing, from $443291.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $1.2 million in Q1 2026 and troughed at $9534.0 in Q1 2023.
- A 5-year average of $409174.1 and a median of $361991.0 in 2025 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2023 and 2024: Treasury Shares tumbled 96.7% in 2023, then soared 5950.37% in 2024.
- A 5-year view of Treasury Shares shows it stood at $19068.0 in 2022, then fell by 18.53% to $15534.0 in 2023, then soared by 5950.37% to $939865.0 in 2024, then tumbled by 52.83% to $443291.0 in 2025, then soared by 161.35% to $1.2 million in 2026.
- Business Quant data shows SLNO's Treasury Shares at $1.2 million in Q1 2026, $443291.0 in Q4 2025, and $469769.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.16 Mn |
| Mar 31, 2026 | 1.16 Mn |
| Dec 31, 2025 | 443,291.00 |
| Dec 31, 2025 | 443,291.00 |
| Sep 30, 2025 | 469,769.00 |
| Sep 30, 2025 | 469,769.00 |
| Jun 30, 2025 | 468,457.00 |
| Jun 30, 2025 | 468,457.00 |
| Mar 31, 2025 | 361,991.00 |
| Mar 31, 2025 | 361,991.00 |
| Dec 31, 2024 | 939,865.00 |
| Dec 31, 2024 | 939,865.00 |
| Sep 30, 2024 | 1.07 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 256,030.00 |
| Jun 30, 2024 | 256,030.00 |
| Mar 31, 2024 | 299,280.00 |
| Mar 31, 2024 | 299,280.00 |
| Dec 31, 2023 | 15,534.00 |
| Dec 31, 2023 | 15,534.00 |